Orthobiology (world market)

2015: Market volume of $4.9 billion

According to Market.Biz analysts, in 2015, the volume of the global orthobiological transplant market used by orthopedic surgeons to quickly heal broken bones and damaged muscles, tendons and ligaments reached $4.9 billion. By 2022, sales of these products will grow by an average of 4.1% per year and amount to about $6.5 billion by the end of this period, researchers predict.

Orthobiological transplant market reached $4.9 billion in 2015

They call North America the largest market for orthobiological materials. The same region will remain a leader until at least 2022. However, the Asia-Pacific region will show the highest growth rates due to the fact that medical literacy is improving here, the economy as a whole is growing, joint businesses are being created in this area, government spending on health care is increasing, and producer mergers are taking place.

The following companies are called the largest producers of orthobiological transplants in Market.Biz:

• Medtronic;
• Sanofi;
• DePuy Synthes;
• Stryker Corporation;
• Integra Lifesciences;
• NuVasive;
• Smith & Nephew;
• Bioventus;
• Wright Medical Technology;
• Zimmer Biomet.

According to the researchers, several factors will contribute to the growth of the market under consideration, including an increase in the number of sports injuries, diseases of osteoarthritis, osteoporosis and obesity. In addition, an increase in the share of the elderly population on the planet, growing investments in research and development, joint projects of leading manufacturers of medical equipment and biotechnology companies are affected, as a result of which a lot of experienced orthobiologists appear on the market.^[1]

Notes